Enzolytics Inc (ENZC)

[falon]

ENZC and us shareholders are about to entered uncharted territory.

Normally with a SPAC a company get bought out by SPAC and become new entity and move on from there.

ENZC is selling two operating subsidiaries which they will be handsomely paid and get a percentage of the newly formed entity.

I expect ENZC shareholders to get shares of SAGA Scientific Holdings Corp.

Will ENZC the company get shares of SAGA Scientific Holdings Corp. to go into its treasury?

Why is this uncharted territory for ENZC?

All the current programs ENZC have been working on are going to be flip into SAGA Scientific Holdings Corp along with personnel.

ITV-1, marketing of IPF Immune™, production of fully human monoclonal antibodies (mAbs) and continued advancement in its proprietary technology involving the application of Artificial Intelligence (AI) in therapeutic discoveries and production.

BGEN will continue to operate under the direction of Dr. Gaurav Chandra as Chairman and CEO and Charles Cotropia as BGEN Director.

VIRO will continue to be managed by Diana Zhabilov as Chairman and CEO and Harry Zhabilov as its CSO and Director, furthering the progress on clinical trials and permitting through the EMA of ITV-1, marketing of IPF Immune™ in the United States as well as registration in Europe, development of the multiple sclerosis treatment and a new initiative involving the use of ITV-1 to treat diabetes. Dr. Lachezar Ivanov will continue to provide invaluable consulting services to VIRO.

Right now the most important technology for ENZC is the ITV-1 therapeutic as it is being deployed to Africa to be administered over a 17 week period once the treatments starts. This will be an international news event at some point during and after the treatment period. What we know about the previous clinical trials for ITV-1 there probably will be good if not great results.

Once the initial patients are treated and when ITV-1 demonstrates effectiveness, the Company expects to provide additional treatments to treat up to 30,000 additional patients living in the Central and Eastern region of Africa.

I checked other ENZC message boards earlier today and found excitement, disbelief, naysayers, bashers and much confusions due to lack of specific information.

It will all become clearer when the deal gets done and more information is released.

Interesting and exciting times are ahead.

AIMHO